首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
【24h】

Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.

机译:新型混合氮杂-氧-硫杂大环化合物的合成,拉曼光谱,FT-IR,NMR光谱表征,抗菌活性,细胞毒性和DNA结合。

获取原文
获取原文并翻译 | 示例
           

摘要

Series of new mixed aza-oxo-thia macrocyclic ligands 1,9(2,6)-ditriazina-2,8,10,16-tetraaza-3,7,11,15-tetraoxo-5,13-dithia-cyclohexade caphan-1(4),9(4)-diphenyl (L(1)); 1,10(2,6)-ditri azina-2,9,11,18-tetraaza-3,8,12,17-tetraoxo-5,6,14,15-tetrathia-cyclooctadecaphan -1(4),10(4)-diphenyl (L(2)); 1,11(2,6)-ditriazina-2,10,12,20-tetraaza-3,9,13,19-tetraoxo-6,16-dithia-cyclocosa -phan-1(4),11(4)-diphenyl (L(3)); 1,12(2,6)-ditriazina-2,11,13,22-tetraaza-3,10,14,21-tetraoxo-6,7,17,18-tetrathia- cyclodocosaphan-1(4),12(4)-diphenyl (L(4)) were synthesised. The structural features of the compounds have been studied by elemental analyses, Mass, FT-Raman, FT-IR, (1)H and (13)C NMR spectroscopy. The antimicrobial activities of the ligands were evaluated using disk diffusion method in dimethyl sulfoxide (DMSO) as well as the minimal inhibitory concentration (MIC) dilution method, against several bacteria and yeast cultures. The obtained results from both methods were assessed in side-by-side comparison with commercial antibacterial and antifungal agents. In most cases, the compounds show strong antifungal activity in the comparison tests. Cytotoxic activities of the ligands against two different human cancer cell lines, stomach (23132/87) and lung (A549) were determined by MTT assay. DNA fragmentation assay tested cell lines were used to analyze the DNA ladder formation which is a characteristic of apoptotic cell death. The binding of the ligands with calf thymus DNA (CT-DNA) has also been investigated by absorption spectroscopy.
机译:系列新的氮杂-氧-硫杂大环配体1,9(2,6)-ditriazina-2,8,10,16-tetraaza-3,7,11,15-tetraoxo-5,13-dithia-cyclohexade caphan -1(4),9(4)-二苯基(L(1)); 1,10(2,6)-ditri azina-2,9,11,18-tetraaza-3,8,12,17-tetraoxo-5,6,14,15-tetrathia-cyclooctadecaphan -1(4),10 (4)-二苯基(L(2)); 1,11(2,6)-ditriazina-2,10,12,20-tetraaza-3,9,13,19-tetraoxo-6,16-dithia-cyclocosa -phan-1(4),11(4) -二苯基(L(3)); 1,12(2,6)-ditriazina-2,11,13,22-tetraaza-3,10,14,21-tetraoxo-6,7,17​​,18-tetrathia-cyclodocosaphan-1(4),12( 4)-二苯基(L(4))被合成。通过元素分析,质谱,FT-拉曼光谱,FT-IR,(1)H和(13)C NMR光谱研究了化合物的结构特征。使用圆盘扩散法在二甲基亚砜(DMSO)中以及最小抑制浓度(MIC)稀释法中评估了配体对几种细菌和酵母菌的抗菌活性。两种方法获得的结果均与市售抗菌剂和抗真菌剂进行了并排比较。在大多数情况下,这些化合物在对比试验中显示出很强的抗真菌活性。通过MTT测定法测定了配体对两种不同的人类癌细胞系胃(23132/87)和肺(A549)的细胞毒活性。经DNA片段化分析测试的细胞系用于分析DNA梯形形成,其是凋亡细胞死亡的特征。还已经通过吸收光谱研究了配体与小牛胸腺DNA(CT-DNA)的结合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号